MONITILLO, LUIGIA
 Distribuzione geografica
Continente #
NA - Nord America 1241
EU - Europa 816
AS - Asia 295
AF - Africa 15
OC - Oceania 2
SA - Sud America 2
Totale 2371
Nazione #
US - Stati Uniti d'America 1225
CN - Cina 229
IT - Italia 125
AT - Austria 122
SE - Svezia 106
IE - Irlanda 101
FR - Francia 83
FI - Finlandia 60
DK - Danimarca 52
DE - Germania 41
UA - Ucraina 39
KR - Corea 31
BE - Belgio 22
PL - Polonia 22
GB - Regno Unito 19
SN - Senegal 15
CA - Canada 14
VN - Vietnam 14
GR - Grecia 13
IN - India 6
SA - Arabia Saudita 6
RU - Federazione Russa 4
UZ - Uzbekistan 4
ES - Italia 3
AU - Australia 2
NL - Olanda 2
PR - Porto Rico 2
BR - Brasile 1
CH - Svizzera 1
CL - Cile 1
IL - Israele 1
IR - Iran 1
KH - Cambogia 1
MD - Moldavia 1
SG - Singapore 1
TR - Turchia 1
Totale 2371
Città #
Chandler 233
Beijing 171
Vienna 122
Ann Arbor 115
Dublin 100
Dearborn 68
Villeurbanne 67
Fairfield 64
Wilmington 61
Houston 58
Woodbridge 54
Torino 46
Nyköping 45
Medford 39
Princeton 31
San Mateo 30
Ashburn 29
Jacksonville 29
Brussels 22
Warsaw 22
Cambridge 20
Pisa 20
Fremont 19
Guangzhou 17
Seattle 16
Milan 15
Dong Ket 10
Toronto 9
Boardman 8
Hefei 7
Nanjing 7
Turin 7
Boston 6
Norwalk 6
Wayne 6
Düsseldorf 5
Mcallen 4
Munich 4
Philadelphia 4
San Jose 4
Auburn Hills 3
Chengdu 3
Florence 3
Phoenix 3
Redwood City 3
San Diego 3
Coimbatore 2
Flushing 2
Jinan 2
Massapequa Park 2
Mountain View 2
Nanchang 2
Naples 2
Ottawa 2
Saint Petersburg 2
San Francisco 2
Shaoxing 2
Sudbury 2
Taranto 2
Zhengzhou 2
Ardabil 1
Arlington 1
Baltimore 1
Baotou 1
Bari 1
Berlin 1
Bilbao 1
Borgaro Torinese 1
Borgo San Dalmazzo 1
Changsha 1
Chaoyang 1
Chicago 1
Chisinau 1
Dallas 1
Delhi 1
Des Moines 1
Duncan 1
Falls Church 1
Fort Belvoir 1
Grevenbroich 1
Groningen 1
Hangzhou 1
Hebei 1
Kunming 1
Köln 1
Madrid 1
New York 1
Ningbo 1
Odesa 1
Omegna 1
Padova 1
Pavia 1
Ramat Gan 1
Redmond 1
San Juan 1
Seoul 1
Sioux Falls 1
Somerville 1
Stockholm 1
São Paulo 1
Totale 1686
Nome #
HashClone: a new tool to quantify the minimal residual disease in B-cell lymphoma from deep sequencing data 364
Prospective molecular monitoring of minimal residual disease after nonmyeloablative allografting in newly diagnosed multiple myeloma 179
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment. 113
High Rates of Prolonged Molecular Remissions After Tandem Autologous-Nonmyeloablative Allografting in Newly Diagnosed Myeloma 111
TELOMERES SHORTEN DURING CHRONIC LYMPHOCYTIC LEUKEMIA(CLL) EVOLUTION: AN ANALYSIS ON 88 CASES 100
Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations 95
Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis 95
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR 88
Telomere length is an independent predictor of survival, treatment requirement and Richter’s syndrome transformation in chronic lymphocytic leukemia 82
Telomere lenght measurement in the clinically oriented research setting: a comparison between Southern blot (SB), real time quantitative PCR (RQ-PCR) and FLOW-FISH (FF) 76
Expression of telomeric proteins in chronic lymphocytic leukemia (CLL) 75
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: Evidences from long term follow-up 74
High Rates of Prolonged Molecular Remissions After Tandem Autologous-Nonmyeloablative Allografting in Newly Diagnosed Myeloma 72
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders 71
Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome 67
Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance. 66
LONG-TERM RESULTS of the GIMEMA VTD Consolidation TRIAL In Autografted MULTIPLE Myeloma PATIENTS (VEL-03-096): IMPACT of Minimal RESIDUAL DISEASE Detection by REAL Time Quantitative PCR On LATE Recurrences and Overall SURVIVAL 66
Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial 66
null 64
Comparison of different DNA extraction methods from peripheral blood cells: advices from the Fondazione Italiana Linfomi - MRD Network. 62
Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia 60
Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients 59
MINIMAL RESIDUAL DISEASE (MRD) DETECTION BY NEXT GENERATION SEQUENCING AND REAL TIME QUANTITATIVE–PCR: A METHODICAL COMPARISON IN ALL, MCL AND MM 55
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders 54
Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans 50
HIGH RATES OF PROLONGED MOLECULAR REMISSIONS AFTER TANDEM AUTOLOGOUS-NONMYELOABLATIVE ALLOGRAFTING IN NEWLY DIAGNOSED MYELOMA 45
COMPARISON OF DIFFERENT RQ-PCR DESIGN STRATEGIES FOR MINIMAL RESIDUAL DISEASE DETECTION IN LYMPHOPROLIFERATIVE DISORDERS: CORRELATION BETWEEN IMMUNOGLOBULIN GENE MUTATION LOAD AND RQ-PCR PERFORMANCE 43
SYNDECAN-1 PROMOTES THE ANGIOGENIC PHENOTYPE OF MULTIPLE MYELOMA ENDOTHELIAL CELLS 39
A COMPARATIVE ANALYSIS OF NEXT GENERATION SEQUENCING AND REAL TIME QUANTITATIVE–PCR FOR MINIMAL RESIDUAL DEECTION IN FOLLICULAR LYMPHOMA 38
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma 27
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma. 12
Totale 2468
Categoria #
all - tutte 4538
article - articoli 0
book - libri 0
conference - conferenze 1510
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6048


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20181 0000 00 00 0001
2018/2019265 85413 614 2850 7445630
2019/2020418 1082066 3069 6524 33344019
2020/2021298 39222319 2612 1915 29174631
2021/2022359 96220 713 6823 92710867
2022/2023596 62661270 47139 4140 6339170
Totale 2468